Soaring cancer-drug costs cause problems for physicians

Hyperexpensive cancer drugs are putting pressure on U.S. oncologists, who have to deal with increasing delays and denials of reimbursement, as well as payment conflicts with drug distributors. Doctors say the trend has influenced their treatment decisions, prompting some to prescribe cheaper alternatives to help patients avoid pricey medicines. As a result, the median income of oncologists in 2006 and 2007 was roughly flat after nearly 10 years of increasing salaries, according to the Medical Group Management Association.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI